4//SEC Filing
Kovacs Shane William Charles 4
Accession 0001415889-24-027022
CIK 0001750284other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:00 AM ET
Size
7.2 KB
Accession
0001415889-24-027022
Insider Transaction Report
Form 4
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-15−25,000→ 162,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2024-11-15$7.02/sh+25,000$175,500→ 510,458 total
Footnotes (2)
- [F1]Includes 471 shares acquired under the issuer's Employee Stock Purchase Plan on June 28, 2024.
- [F2]25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001579397
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 6:00 AM ET
- Size
- 7.2 KB